The poly ADP-ribose polymerase 1 (PARP1) inhibitor BYK204165 antagonized the cytotoxic effects of fascaplysin, indicating that DNA repair was involved in its anti-tumor effects. This evidence concerns the gene PARP1 and neoplasm.